A detailed history of Summit Partners Public Asset Management, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Summit Partners Public Asset Management, LLC holds 617,440 shares of GKOS stock, worth $87.3 Million. This represents 2.89% of its overall portfolio holdings.

Number of Shares
617,440
Previous 410,907 50.26%
Holding current value
$87.3 Million
Previous $48.6 Million 65.41%
% of portfolio
2.89%
Previous 2.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$113.62 - $135.39 $23.5 Million - $28 Million
206,533 Added 50.26%
617,440 $80.4 Million
Q2 2024

Aug 14, 2024

BUY
$89.48 - $118.35 $36.8 Million - $48.6 Million
410,907 New
410,907 $48.6 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.73B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Summit Partners Public Asset Management, LLC Portfolio

Follow Summit Partners Public Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.